Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response
University of Helsinki · Helsinki University Hospital · +6 more institutions
Abstract
Colorectal cancer (CRC) remains refractory to most immunotherapies, with cancer vaccines failing due to an immunosuppressive tumor microenvironment. Here, we show that β-glucan–induced trained immunity overcomes these barriers by reprogramming macrophages through H3K4me3-dependent epigenetic modifications and metabolic rewiring. In female mice vaccinated with peptide-coated adenovirus-based vaccine PeptiCrad, training enhances glycolysis with creatine metabolism sustaining CXCL9/10 production, enabling macrophages to recruit NK cells via CXCR3. In turn, NK cells produce CCL5, driving cDC1 infiltration and antigen presentation, which together amplify effector memory CD8⁺ T cell responses. Moreover, with human…
Citation impact
- FWCI
- 44.03
- Percentile
- 100%
- References
- 55
Authors
25Topics & keywords
- Colorectal cancer
- Immunity
- Reprogramming
- Epigenetics
- Immune system
- Adjuvant
- Peripheral blood mononuclear cell
- Innate immune system
- Good health and well-being
Funding
- HYHelsingin Yliopisto
- JJJane ja Aatos Erkon SäätiöAwards: 797011004, 4705796
- MEMagnus Ehrnroothin SäätiöAward: 4706235
- UDUniversidad de Navarra
- SSyöpäsäätiöAward: 4706116
- BFBiocenter Finland
- H2Horizon 2020 Framework ProgrammeAward: 681219
- HIHelsinki Institute of Life Science, Helsingin YliopistoAward: 797011004